Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Chulmin Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)
E Sun Paik, Myong Cheol Lim, Moon-Hong Kim, Yun Hwan Kim, Eun Seop Song, Seok Ju Seong, Dong Hoon Suh, Jong-Min Lee, Chulmin Lee, Chel Hun Choi
Cancer Res Treat. 2020;52(1):320-333.   Published online August 5, 2019
DOI: https://doi.org/10.4143/crt.2019.124
AbstractAbstract PDFPubReaderePub
Purpose
We aimed to develop and validate individual prognostic models in a large cohort of cervical cancer patients that were primarily treated with radical hysterectomy.
Materials and Methods
We analyzed 1,441 patients with early-stage cervical cancer treated between 2000 and 2008 from the Korean Gynecologic Oncology Group multi-institutional cohort: a train cohort (n=788) and a test cohort (n=653). Models predicting the risk for overall survival (OS), disease- free survival (DFS), lymphatic recurrence and hematogenous recurrence were developed using Cox analysis and stepwise backward selection and best-model options. The prognostic performance of each model was assessed in an independent patient cohort. Model-classified risk groups were compared to groups based on traditional risk factors.
Results
Independent risk factors for OS, DFS, lymphatic recurrence, and hematogenous recurrence were identified for prediction model development. Different combinations of risk factors were shown for each outcome with best predictive value. In train cohort, area under the curve (AUC) at 2 and 5 years were 0.842/0.836 for recurrence, and 0.939/0.882 for OS. When applied to a test cohort, the model also showed accurate prediction result (AUC at 2 and 5 years were 0.799/0.723 for recurrence, and 0.844/0.806 for OS, respectively). The Kaplan-Meier plot by proposed model-classified risk groups showed more distinctive survival differences between each risk group.
Conclusion
We developed prognostic models for OS, DFS, lymphatic and hematogenous recurrence in patients with early-stage cervical cancer. Combining weighted clinicopathologic factors, the proposed model can give more individualized predictions in clinical practice.

Citations

Citations to this article as recorded by  
  • Lymphovascular Space Invasion in Cervical Cancer: A Review of Clinical Significance and Pathologic Issues
    Simona Stolnicu, Karen L. Talia, Natalie Banet, W. Glenn McCluggage, David Cibula
    International Journal of Gynecological Pathology.2026; 45(2): 152.     CrossRef
  • External validation of the annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer
    Luigi A. De Vitis, Gabriella Schivardi, Aurora Gaeta, Giuseppe Caruso, Marina Rosanu, Lucia Ribero, Diletta Fumagalli, Jvan Casarin, Ilaria Betella, Giorgio Bogani, Carrie L. Langstraat, Giovanni D. Aletti, Nicoletta Colombo, Vanna Zanagnolo, Sara Gandini
    International Journal of Gynecological Cancer.2025; 35(6): 101756.     CrossRef
  • Stratification by Mutational Landscape Reveals Differential Immune Infiltration and Predicts the Recurrence and Clinical Outcome of Cervical Cancer
    Chun Gao, Qian Zhou, Liting Liu, Hong Liu, Yifan Yang, Shen Qu, Qing He, Yafei Huang, Ximiao He, Hui Wang
    Phenomics.2025; 5(4): 384.     CrossRef
  • Which factors predict the effectiveness of adjuvant treatment in patients with non-high-risk early-stage cervical cancer? Ancillary analysis of KGOG-1028
    Junhwan Kim, Jieun Jang, Myong Cheol Lim, Moon-Hong Kim, Yun Hwan Kim, Eun Seop Song, Seok Ju Seong, Dong Hoon Suh, Jong-Min Lee, Chulmin Lee, Chel Hun Choi, Sokbom Kang
    Gynecologic Oncology.2025; 196: 10.     CrossRef
  • Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteria
    Jaekyung Bae, Uisuk Kim, E. Sun Paik, Myong Cheol Lim, Moon-Hong Kim, Yun Hwan Kim, Eun Seop Song, Seok Ju Seong, Dong Hoon Suh, Jong-Min Lee, Chulmin Lee, Chel Hun Choi, Sokbom Kang
    Gynecologic Oncology.2025; 197: 91.     CrossRef
  • Development and Internal-External Validation Models for Cervical Cancer Overall Survival Prognosis: A SEER-Based Study and Chinese Data
    Yao Shi, Jia-Nan Xu, Qi-Qin Wang, Si-Yuan Wang, Lan-Ying Wang
    International Journal of Women's Health.2025; Volume 17: 2051.     CrossRef
  • Modelling a novel approach for cervical cancer prediction using pre-trained network model
    S. Devi, Vijayakumar Adaickalam
    International Journal of System Assurance Engineering and Management.2025;[Epub]     CrossRef
  • Multiparametric MRI-based radiomics nomogram for identifying cervix-corpus junction cervical adenocarcinoma from endometrioid adenocarcinoma
    Yuhan Fang, Keying Wang, Meiling Xiao, Jiejun Cheng, Zijing Lin, Jinwei Qiang, Ying Li
    Abdominal Radiology.2024; 49(5): 1557.     CrossRef
  • Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042)
    Woo Yeon Hwang, Chel Hun Choi, Kidong Kim, Moon-Hong Kim, Myong Cheol Lim, Banghyun Lee, Myounghwan Kim, Yun Hwan Kim, Seok Ju Seong, Jong-Min Lee
    Obstetrics & Gynecology Science.2024; 67(3): 296.     CrossRef
  • Predictive models for personalized precision medical intervention in spontaneous regression stages of cervical precancerous lesions
    Simin He, Guiming Zhu, Ying Zhou, Boran Yang, Juping Wang, Zhaoxia Wang, Tong Wang
    Journal of Translational Medicine.2024;[Epub]     CrossRef
  • From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps
    Kyung-Jin Min, Nam Kyeong Kim, Jae-Yun Song, Min Chul Choi, Shin Wha Lee, Keun Ho Lee, Min Kyu Kim, Sokbom Kang, Chel Hun Choi, Jeong-Won Lee, Eun-Ju Lee, Keun-Yong Eom, Sang Wun Kim, Hanbyoul Cho, Sun Joo Lee, Myong Cheol Lim, Jaeman Bae, Chong Woo Yoo,
    Cancers.2024; 16(19): 3422.     CrossRef
  • Prognostic Factors for Cervical Cancer in Asian Populations: A Scoping Review of Research From 2013 to 2023
    Syed S Abrar, Seoparjoo Azmel Mohd Isa, Suhaily Mohd Hairon, Najib M Yaacob, Mohd Pazudin Ismail
    Cureus.2024;[Epub]     CrossRef
  • Radiomics based on MRI in predicting lymphovascular space invasion of cervical cancer: a meta-analysis
    Chongshuang Yang, Min Wu, Jiancheng Zhang, Hongwei Qian, Xiangyang Fu, Jing Yang, Yingbin Luo, Zhihong Qin, Tianliang Shi
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Systematic review and meta-analysis of prediction models used in cervical cancer
    Ashish Kumar Jha, Sneha Mithun, Umeshkumar B. Sherkhane, Vinay Jaiswar, Biche Osong, Nilendu Purandare, Sadhana Kannan, Kumar Prabhash, Sudeep Gupta, Ben Vanneste, Venkatesh Rangarajan, Andre Dekker, Leonard Wee
    Artificial Intelligence in Medicine.2023; 139: 102549.     CrossRef
  • Selective photodynamic effects on cervical adenocarcinoma cells provided by F127 Pluronic®-based micelles modulating hypericin delivery
    Kayane Harumi Mashiba, Lucimara Rofrigues Carobeli, Maria Vítoria Felipe de Souza, Lyvia Eloiza de Freitas Meirelles, Natália Lourenço Mari, Gabriel Batista César, Renato Sonchini Gonçalves, Wilker Caetano, Edilson Damke, Vânia Ramos Sela da Silva, Gabrie
    Brazilian Journal of Pharmaceutical Sciences.2023;[Epub]     CrossRef
  • Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study
    Teska N Schuurman, Mirte Schaafsma, Kaylee H To, Viola M J Verhoef, Karolina Sikorska, Albert G Siebers, Hans H B Wenzel, Maaike C G Bleeker, Eva Maria Roes, Ronald P Zweemer, Peggy J de Vos van Steenwijk, Refika Yigit, Jogchum J Beltman, Petra L M Zuster
    The Lancet Oncology.2023; 24(12): 1349.     CrossRef
  • Surgical Treatment for Early Cervical Cancer in the HPV Era: State of the Art
    Mario Palumbo, Luigi Della Corte, Carlo Ronsini, Serena Guerra, Pierluigi Giampaolino, Giuseppe Bifulco
    Healthcare.2023; 11(22): 2942.     CrossRef
  • Comparison of treatment modalities for selected advanced laryngeal squamous cell carcinoma
    Aihemaiti Wushouer, Wenming Li, Minfa Zhang, Dapeng Lei, Xinliang Pan
    European Archives of Oto-Rhino-Laryngology.2022; 279(1): 361.     CrossRef
  • The positive threshold of the immunohistochemical parameter Ki67 for predicting the recurrence of cervical cancer
    Yuan Tu, Peng Jiang, Jingni Zhang, Shan Jiang, Qianlin Yi, Rui Yuan
    International Journal of Gynecology & Obstetrics.2022; 158(2): 330.     CrossRef
  • Management of Early-Stage Cervical Cancer: A Literature Review
    Yasmin Medeiros Guimarães, Luani Rezende Godoy, Adhemar Longatto-Filho, Ricardo dos Reis
    Cancers.2022; 14(3): 575.     CrossRef
  • The Value of Whole-Tumor Texture Analysis of ADC in Predicting the Early Recurrence of Locally Advanced Cervical Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy
    Xiaomiao Zhang, Qi Zhang, Lizhi Xie, Jusheng An, Sicong Wang, Xiaoduo Yu, Xinming Zhao
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • The recurrences of cervical cancer: Possibilities of molecular prediction
    L. A. Ashrafyan, T. E. Belokrinitskaya, L. F. Sholokhov, E. V. Kayukova, V. A. Mudrov
    Acta Biomedica Scientifica.2022; 7(2): 34.     CrossRef
  • Modern diagnostics and treatment of distant metastasis of cervical cancer
    R. K. Minyazeva, G. Y. Battalova, I. V. Sakhautdinova, I. R. Gilyazova
    Creative surgery and oncology.2022; 12(2): 128.     CrossRef
  • Clinical Outcomes and Their Prognostic Factors among Cervical Cancer Patients with Bone Recurrence
    Thiti Atjimakul, Jitti Hanprasertpong, Enrique Hernandez
    Obstetrics and Gynecology International.2022; 2022: 1.     CrossRef
  • Adjuvant radiotherapy for cervical cancer in South Korea: a radiation oncology survey of the Korean Radiation Oncology Group (KROG 20-06)
    Nalee Kim, Won Park
    Japanese Journal of Clinical Oncology.2021; 51(7): 1107.     CrossRef
  • Prediction Models for Prognosis of Cervical Cancer: Systematic Review and Critical Appraisal
    Bingjie He, Weiye Chen, Lili Liu, Zheng Hou, Haiyan Zhu, Haozhe Cheng, Yixi Zhang, Siyan Zhan, Shengfeng Wang
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features
    Nalee Kim, Won Park, Won Kyung Cho, Duk-Soo Bae, Byoung-Gie Kim, Jeong-Won Lee, Chel Hun Choi, Tae-Joong Kim, Yoo-Young Lee
    Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
  • The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer
    David Cibula, Lukáš Dostálek, Jiri Jarkovsky, Constantijne H. Mom, Aldo Lopez, Henrik Falconer, Anna Fagotti, Ali Ayhan, Sarah H. Kim, David Isla Ortiz, Jaroslav Klat, Andreas Obermair, Fabio Landoni, Juliana Rodriguez, Ranjit Manchanda, Jan Kosťun, Ricar
    European Journal of Cancer.2021; 158: 111.     CrossRef
  • Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach
    Lin Xie, Ran Chu, Kai Wang, Xi Zhang, Jie Li, Zhe Zhao, Shu Yao, Zhiwen Wang, Taotao Dong, Xingsheng Yang, Xuantao Su, Xu Qiao, Kun Song, Beihua Kong
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • 12,788 View
  • 309 Download
  • 29 Web of Science
  • 29 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP